Joseph Andrew DeSimone MD
Assistant Clinical Professor of Medicine, Jefferson Medical College
Join to View Full Profile
1015 Chestnut StSuite 1020Philadelphia, PA 19107
Phone+1 215-955-7785
Fax+1 215-955-9362
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joseph DeSimone, MD is an infectious disease specialist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Thomas Jefferson University Hospital and is an Assistant Clinical Professor of Medicine at Jefferson Medical College.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Infectious Disease, 1997 - 1999- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1994 - 1997
Drexel University College of MedicineClass of 1994
MCP-Hahnemann College of MedicineClass of 1994
Certifications & Licensure
PA State Medical License 1995 - 2026- PA State Medical License 1997 - 2026
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012-2017
Publications & Presentations
PubMed
- 57 citationsChanges in Body Mass Index and Atherosclerotic Disease Risk Score After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide.Jason J. Schafer, Kaitlin N Sassa, Jaclyn R O'Connor, Ayako Shimada, Scott W. Keith
Open Forum Infectious Diseases. 2019-10-01 - 18 citationsOral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboonsAngela Rivers, Kestis Vaitkus, Ramasamy Jagadeeswaran, Maria Armila Ruiz, Vinzon Ibanez
Experimental Hematology. 2018-11-01 - 2 citationsAnswer to October 2017 Photo Quiz.Puja H. Nambiar, Mindy J. Tokarczyk, Joseph A. DeSimone
Journal of Clinical Microbiology. 2017-10-01
